Monte Rosa Therapeutics, Inc. (GLUE)
19.55
+0.65
(+3.44%)
USD |
NASDAQ |
Feb 06, 16:00
19.53
-0.02
(-0.10%)
After-Hours: 20:00
Monte Rosa Therapeutics Market Cap : 1.273B for Feb. 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.412B |
| Pfizer Inc. | 154.76B |
| CorMedix, Inc. | 605.89M |
| Zoetis, Inc. | 56.15B |
| Alumis, Inc. | 2.734B |
Market Cap Related Metrics
| PE Ratio | 64.01 |
| PS Ratio | 8.320 |
| Price to Book Value | 5.178 |
| Price to Free Cash Flow | 10.42 |
| Price | 19.55 |
| Earnings Yield | 1.56% |
| Operating PE Ratio | 177.47 |
| Normalized PE Ratio | 64.01 |